Literature DB >> 29299192

An atypical case of craniometaphyseal dysplasia. Case report and surgical treatment.

Giorgio Novelli1, Emanuela Ardito1, Fabio Mazzoleni1, Alberto Bozzetti1, Davide Sozzi1.   

Abstract

INTRODUCTION: Craniometaphyseal dysplasia is a rare hereditary bone disease presenting metaphyseal widening of the tubular bones, sclerosis of craniofacial bones and bony overgrowth of the facial and skull bones. Craniometaphyseal dysplasia occurs in an autosomal dominant (AD) and an autosomal recessive (AR) form. CASE REPORT: We present a 32-year-old patient arrived at our unit in May 2009. His main discomfort was a major limitation of the mouth opening, in the context of a craniofacial deformity. Relying on patient's medical history and the performed diagnostic tests, the diagnosis of craniometaphyseal dysplasia was made.
CONCLUSION: After careful evaluation of the clinical case, in accordance with the requirements of the patient, we opted for a surgical treatment aimed at correction of functional limitation of temporomandibular joint and aesthetic improvement of the facial bones. The stability of the clinical results led us to suggest and to undertake the surgical path, also due to the lack of safe and consolidated non-surgical treatments for the specific case.

Entities:  

Keywords:  ANKH; CMD; craniometaphyseal dysplasia

Year:  2017        PMID: 29299192      PMCID: PMC5749377          DOI: 10.11138/ads/2017.8.2.045

Source DB:  PubMed          Journal:  Ann Stomatol (Roma)        ISSN: 1824-0852


  13 in total

1.  Craniometaphyseal dysplasia: a case report and review of medical and surgical management.

Authors:  William M Sheppard; Robert J Shprintzen; Sherard A Tatum; Charles I Woods
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-06       Impact factor: 1.675

2.  Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK.

Authors:  E Reichenberger; V Tiziani; S Watanabe; L Park; Y Ueki; C Santanna; S T Baur; R Shiang; D K Grange; P Beighton; J Gardner; H Hamersma; S Sellars; R Ramesar; A C Lidral; A Sommer; C M Raposo do Amaral; R J Gorlin; J B Mulliken; B R Olsen
Journal:  Am J Hum Genet       Date:  2001-04-16       Impact factor: 11.025

3.  Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia.

Authors:  P Nürnberg; H Thiele; D Chandler; W Höhne; M L Cunningham; H Ritter; G Leschik; K Uhlmann; C Mischung; K Harrop; J Goldblatt; Z U Borochowitz; D Kotzot; F Westermann; S Mundlos; H S Braun; N Laing; S Tinschert
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

4.  Craniometaphyseal dysplasia: a case report.

Authors:  Luca Lamazza; Antonello Messina; Ferdinando D'Ambrosio; Michael Spink; Alberto De Biase
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-05

5.  Craniometaphyseal dysplasia.

Authors:  Young Ho Kim; Dong Hwan Roh; Byung Yoon Choi; Seung-Ha Oh
Journal:  Acta Otolaryngol       Date:  2005-07       Impact factor: 1.494

6.  Craniometaphyseal dysplasia (CMD), autosomal dominant form.

Authors:  P Beighton
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

7.  Biochemical and genetic analysis of ANK in arthritis and bone disease.

Authors:  Kyle A Gurley; Richard J Reimer; David M Kingsley
Journal:  Am J Hum Genet       Date:  2006-10-16       Impact factor: 11.025

8.  Role of the mouse ank gene in control of tissue calcification and arthritis.

Authors:  A M Ho; M D Johnson; D M Kingsley
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

9.  Mapping of the autosomal recessive (AR) craniometaphyseal dysplasia locus to chromosome region 6q21-22 and confirmation of genetic heterogeneity for mild AR spondylocostal dysplasia.

Authors:  P Iughetti; L G Alonso; W Wilcox; N Alonso; M R Passos-Bueno
Journal:  Am J Med Genet       Date:  2000-12-18

10.  Craniofacial surgery for craniometaphyseal dysplasia.

Authors:  F U Ahmad; A K Mahapatra; H Mahajan
Journal:  Neurol India       Date:  2006-03       Impact factor: 2.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.